TAK-218
Product Specifications
UNSPSC Description
TAK-218 is a promising candidate as an agent tor central nervous system trauma and ischemia. TAK-218 exhibits potent scavenging activity and antioxidative activity. TAK-218 also inhibits dopamine release[1].
Target Antigen
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tak-218.html
Smiles
CC1=C2C(O[C@@](C)(C2)CN3CCC(C4=CC=CC=C4)CC3)=C(C(C)=C1N)C.Cl.Cl
Molecular Weight
437.45
References & Citations
[1]Morio MURAKAMI, et al. ESR Study on the Antioxidant Activity of TAK-218 in Biological Model Membranes. Chem. Pharm. Bull. 48(6)784-792 (2000).
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19262/TAK-218-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19262/
Clinical Information
Phase 2
CAS Number
156756-10-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1113148-01 1 mg (E-Coli)
Recombinant Lodderomyces elongisporus Probable zinc metalloprotease LELG_02615 (LELG_02615)
Ask
View Details MBS1113148-02 1 mg (Yeast)
Recombinant Lodderomyces elongisporus Probable zinc metalloprotease LELG_02615 (LELG_02615)
Ask
View Details 